208 related articles for article (PubMed ID: 8104032)
1. Neurobiological investigations into the role of cholecystokinin in panic disorder.
Bradwejn J
J Psychiatry Neurosci; 1993 Jul; 18(4):178-88. PubMed ID: 8104032
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin and panic disorder: past and future clinical research strategies.
Bradwejn J; Koszycki D
Scand J Clin Lab Invest Suppl; 2001; 234():19-27. PubMed ID: 11713976
[TBL] [Abstract][Full Text] [Related]
3. [Is cholecystokinin a biological support in panic attacks?].
Bourin M; Bradwejn J; Koszycki D
Encephale; 1991; 17(5):475-9. PubMed ID: 1686250
[TBL] [Abstract][Full Text] [Related]
4. [From inducers of panic attack to neurobiology of panic disorder].
Bourin M
Encephale; 1996 Dec; 22 Spec No 5():35-41. PubMed ID: 9138945
[TBL] [Abstract][Full Text] [Related]
5. Quantitation and identification of two cholecystokinin peptides, CCK-4 and CCK-8s, in rat brain by HPLC and fast atom bombardment mass spectrometry.
Qureshi GA; Bednar I; Min Q; Södersten P; Silberring J; Nyberg F; Thörnwall M
Biomed Chromatogr; 1993; 7(5):251-5. PubMed ID: 8305854
[TBL] [Abstract][Full Text] [Related]
6. Aging and panicogenic response to cholecystokinin tetrapeptide: an examination of the cholecystokinin system.
Flint A; Bradwejn J; Vaccarino F; Gutkowska J; Palmour R; Koszycki D
Neuropsychopharmacology; 2002 Oct; 27(4):663-71. PubMed ID: 12377403
[TBL] [Abstract][Full Text] [Related]
7. Central cholecystokinin activity in irritable bowel syndrome, panic disorder, and healthy controls.
Koszycki D; Torres S; Swain JE; Bradwejn J
Psychosom Med; 2005; 67(4):590-5. PubMed ID: 16046372
[TBL] [Abstract][Full Text] [Related]
8. [Neuropharmacological and genetic study of panic disorder].
Akiyoshi J
Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Jul; 19(3):93-9. PubMed ID: 10495983
[TBL] [Abstract][Full Text] [Related]
9. Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients.
Bradwejn J; Koszycki D
Am J Psychiatry; 1994 Feb; 151(2):261-3. PubMed ID: 8296900
[TBL] [Abstract][Full Text] [Related]
10. Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses.
Abelson JL; Nesse RM
Biol Psychiatry; 1994 Jul; 36(2):73-83. PubMed ID: 7948449
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity to cholecystokinin-tetrapeptide in major depression.
Koszycki D; Copen J; Bradwejn J
J Affect Disord; 2004 Jun; 80(2-3):285-90. PubMed ID: 15207943
[TBL] [Abstract][Full Text] [Related]
12. The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder.
van Megen HJ; Westenberg HG; Den Boer JA; Kahn RS
Eur Neuropsychopharmacol; 1996 Aug; 6(3):187-94. PubMed ID: 8880078
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin and panic disorder--three unsettled questions.
Rehfeld JF
Regul Pept; 2000 Sep; 93(1-3):79-83. PubMed ID: 11033055
[TBL] [Abstract][Full Text] [Related]
14. Missense mutation of the cholecystokinin B receptor gene: lack of association with panic disorder.
Kato T; Wang ZW; Zoega T; Crowe RR
Am J Med Genet; 1996 Jul; 67(4):401-5. PubMed ID: 8837709
[TBL] [Abstract][Full Text] [Related]
15. Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers.
Maron E; Tõru I; Tasa G; Must A; Toover E; Lang A; Vasar V; Shlik J
Neurosci Lett; 2008 Dec; 446(2-3):88-92. PubMed ID: 18832011
[TBL] [Abstract][Full Text] [Related]
16. Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze.
Zanoveli JM; Netto CF; Guimarães FS; Zangrossi H
Peptides; 2004 Nov; 25(11):1935-41. PubMed ID: 15501525
[TBL] [Abstract][Full Text] [Related]
17. Distinct panicogenic activity of sodium lactate and cholecystokinin tetrapeptide in patients with panic disorder.
Plag J; Gaudlitz K; Zschucke E; Yassouridis A; Pyrkosch L; Wittmann A; Holsboer F; Ströhle A
Curr Pharm Des; 2012; 18(35):5619-26. PubMed ID: 22632477
[TBL] [Abstract][Full Text] [Related]
18. The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers.
Maron E; Tõru I; Vasar V; Shlik J
J Psychopharmacol; 2004 Jun; 18(2):194-9. PubMed ID: 15260907
[TBL] [Abstract][Full Text] [Related]
19. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.
Bertoglio LJ; Zangrossi H
Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dog.
Fossa AA; DePasquale MJ; Morrone J; Zorn SH; Bryce D; Lowe JA; McLean S
J Pharmacol Exp Ther; 1997 Apr; 281(1):180-7. PubMed ID: 9103496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
